arginine has been researched along with Cardio-Renal Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, CR; Elias, BC; Fukami, K; Taguchi, K; Ueda, S | 1 |
| Castellino, P; Fatuzzo, P; Gaudio, A; Granata, A; Lentini, P; Malatino, L; Rapisarda, F; Sessa, C; Xourafa, A; Zanoli, L | 1 |
| De Miguel, C; Hutchens, MP | 1 |
| Okuda, S; Ueda, S; Yamagishi, S; Yokoro, M | 1 |
| Bassareo, PP; Fanos, V; Flore, G; Mercuro, G; Mussap, M; Noto, A; Puddu, M; Saba, L | 1 |
| Barberini, L; Bassareo, PP; Fanos, V; Flore, G; Mercuro, G; Noto, A; Puddu, M; Solla, P | 1 |
| Kaye, DM; Nanayakkara, S; Rajapakse, NW | 1 |
| Righetti, M | 1 |
5 review(s) available for arginine and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Uremic Toxin-Targeting as a Therapeutic Strategy for Preventing Cardiorenal Syndrome.
Topics: Arginine; Cardio-Renal Syndrome; Glycation End Products, Advanced; Humans; Methylamines; Renal Insufficiency, Chronic | 2019 |
[Vascular dysfunction in Cardiorenal Syndrome type 4].
Topics: Aorta; Arginine; Autonomic Nervous System Diseases; Bone Diseases, Metabolic; Cardio-Renal Syndrome; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Phosphorus; Renal Insufficiency, Chronic; Toxins, Biological; Tunica Intima; Uric Acid; Vascular Stiffness; Vasculitis | 2020 |
Role of asymmetric dimethylarginine in cardiorenal syndrome.
Topics: Animals; Arginine; Cardio-Renal Syndrome; Cardiovascular Agents; Drug Delivery Systems; Humans; Nitric Oxide Synthase | 2014 |
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.
Topics: Anti-Inflammatory Agents; Arginine; Biological Transport; Cardio-Renal Syndrome; Cardiovascular Agents; Cationic Amino Acid Transporter 1; Diuretics; Endothelium, Vascular; Erythropoietin; Heart; Hemodynamics; Humans; Inflammation Mediators; Kidney; Nitric Oxide; Oxidative Stress; Sympathetic Nervous System | 2015 |
Cardio-renal-anemia syndrome: a link between erythropoietin, dimethylarginine and homocysteine.
Topics: Anemia; Animals; Arginine; Cardio-Renal Syndrome; Erythropoietin; Homocysteine; Humans; Nitric Oxide Synthase; Vitamin B Complex | 2012 |
3 other study(ies) available for arginine and Cardio-Renal Syndrome
| Article | Year |
|---|---|
The CAT-1 is out of the bag: endothelial Cationic Amino Acid Transporter-1 is a critical player in cardiorenal syndrome type 2.
Topics: Arginine; Cardio-Renal Syndrome; Cationic Amino Acid Transporter 1; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II | 2021 |
Urinary NGAL and hematic ADMA levels: an early sign of cardio-renal syndrome in young adults born preterm?
Topics: Acute-Phase Proteins; Adolescent; Adult; Adult Children; Arginine; Cardio-Renal Syndrome; Case-Control Studies; Female; Humans; Infant, Newborn; Infant, Premature; Lipocalin-2; Lipocalins; Male; Pregnancy; Premature Birth; Prognosis; Proto-Oncogene Proteins; Young Adult | 2013 |
Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm.
Topics: Adult; Arginine; Cardio-Renal Syndrome; Case-Control Studies; Discriminant Analysis; Female; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Least-Squares Analysis; Male; Metabolomics; Premature Birth; Young Adult | 2014 |